Table 3a:
Cumulative incidence over time (and 95% CI) of AML or MDS after autotransplant according to diagnosis group (with death as the competing risk)
| Diagnosis | |||
|---|---|---|---|
| Time post transplant |
HL (n = 915) |
NHL (n = 3,540) |
PCM (n = 4,563) |
| 1-year | 0(0–1)% | 1(0–1)% | 0(0–0)% |
| 3-year | 1(1–2)% | 2(2–3)% | 1(0–1)% |
| 5-year | 3(2–4)% | 4(3–5)% | 1(1–2)% |
| 10-year | 4(3–6)% | 6(5–7)% | 3(2–3)% |